loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering Carfilzomib

    Client Email Product
    Menu

    Carfilzomib

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ONYX PHARMS AMGEN (57)

    filter

    01 7232818 (3)

    02 7417042 (3)

    03 7491704 (11)

    04 7737112 (3)

    05 8129346 (11)

    06 8207125 (3)

    07 8207126 (3)

    08 8207127 (11)

    09 8207297 (3)

    10 9493582 (3)

    11 RE47954 (3)

    filter

    01 Y (12)

    02 Blank (45)

    filter

    01 Y (21)

    02 Blank (36)

    filter

    01 2025-04-14 (45)

    02 2026-07-20 (3)

    03 2027-12-07 (3)

    04 2029-10-21 (3)

    05 2033-02-27 (3)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    ONYX PHARMS AMGEN

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      CARFILZOMIB

      PDF Supplier PDF
      URL Supplier Web Content
      7491704
      2025-04-14
      U-1260
      202714
      TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST TWO PRIOR THERAPIES INCLUDING BORTEZOMIB AND AN IMMUNOMODULATORY AGENT AND HAVE
      1
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      ONYX PHARMS AMGEN

      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        CARFILZOMIB

        PDF Supplier PDF
        URL Supplier Web Content
        8207127
        2025-04-14
        U-1260
        202714
        TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST TWO PRIOR THERAPIES INCLUDING BORTEZOMIB AND AN IMMUNOMODULATORY AGENT AND HAVE
        2
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content

        ONYX PHARMS AMGEN

        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          CARFILZOMIB

          PDF Supplier PDF
          URL Supplier Web Content
          7491704
          2025-04-14
          U-2319
          202714
          3
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          ONYX PHARMS AMGEN

          Contact Supplier
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            CARFILZOMIB

            PDF Supplier PDF
            URL Supplier Web Content
            8207127
            2025-04-14
            U-2320
            202714
            3
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            ONYX PHARMS AMGEN

            Contact Supplier
              Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
              Post an Enquiry Post an Enquiry
              Flag U.S.A
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              CARFILZOMIB

              PDF Supplier PDF
              URL Supplier Web Content
              8129346
              2025-04-14
              U-2320
              202714
              3
              ASK
              US
              PHARMACOMPASS
              Upload
              your Marketing & Sales content

              ONYX PHARMS AMGEN

              Contact Supplier
                Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
                Post an Enquiry Post an Enquiry
                Flag U.S.A
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                CARFILZOMIB

                PDF Supplier PDF
                URL Supplier Web Content
                8129346
                2025-04-14
                U-2319
                202714
                3
                ASK
                US
                PHARMACOMPASS
                Upload
                your Marketing & Sales content

                ONYX PHARMS AMGEN

                Contact Supplier
                  Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
                  Post an Enquiry Post an Enquiry
                  Flag U.S.A
                  Virtual Booth Virtual Booth
                  Digital Content Digital Content

                  CARFILZOMIB

                  PDF Supplier PDF
                  URL Supplier Web Content
                  8207127
                  2025-04-14
                  U-1260
                  202714
                  TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST TWO PRIOR THERAPIES INCLUDING BORTEZOMIB AND AN IMMUNOMODULATORY AGENT AND HAVE
                  1
                  ASK
                  US
                  PHARMACOMPASS
                  Upload
                  your Marketing & Sales content

                  ONYX PHARMS AMGEN

                  Contact Supplier
                    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
                    Post an Enquiry Post an Enquiry
                    Flag U.S.A
                    Virtual Booth Virtual Booth
                    Digital Content Digital Content

                    CARFILZOMIB

                    PDF Supplier PDF
                    URL Supplier Web Content
                    8129346
                    2025-04-14
                    U-1260
                    202714
                    TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST TWO PRIOR THERAPIES INCLUDING BORTEZOMIB AND AN IMMUNOMODULATORY AGENT AND HAVE
                    2
                    ASK
                    US
                    PHARMACOMPASS
                    Upload
                    your Marketing & Sales content

                    ONYX PHARMS AMGEN

                    Contact Supplier
                      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
                      Post an Enquiry Post an Enquiry
                      Flag U.S.A
                      Virtual Booth Virtual Booth
                      Digital Content Digital Content

                      CARFILZOMIB

                      PDF Supplier PDF
                      URL Supplier Web Content
                      8129346
                      2025-04-14
                      U-1260
                      202714
                      TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST TWO PRIOR THERAPIES INCLUDING BORTEZOMIB AND AN IMMUNOMODULATORY AGENT AND HAVE
                      1
                      ASK
                      US
                      PHARMACOMPASS
                      Upload
                      your Marketing & Sales content

                      ONYX PHARMS AMGEN

                      Contact Supplier
                        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
                        Post an Enquiry Post an Enquiry
                        Flag U.S.A
                        Virtual Booth Virtual Booth
                        Digital Content Digital Content

                        CARFILZOMIB

                        PDF Supplier PDF
                        URL Supplier Web Content
                        7491704
                        2025-04-14
                        U-1260
                        202714
                        TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST TWO PRIOR THERAPIES INCLUDING BORTEZOMIB AND AN IMMUNOMODULATORY AGENT AND HAVE
                        2
                        ASK
                        US
                        PHARMACOMPASS
                        Upload
                        your Marketing & Sales content
                        Post Enquiry
                        POST ENQUIRY